Expression of uncoupling protein-3 in subsarcolemmal
and intermyofibrillar mitochondria of various mouse muscle
types and its modulation by fasting
Maria Jimenez, Cedric Yvon, Lorenz Lehr, Bertrand Le
´ger, Patrick Keller, Aaron Russell, Franc¸oise Kuhne,
Pierre Flandin, Jean-Paul Giacobino and Patrick Muzzin
Department of Medical Biochemistry, Faculty of Medicine, University of Geneva, Switzerland
Uncoupling protein-3 (UCP3) is a mitochondrial inner-
membrane protein abundantly expressed in rodent and
human skeletal muscle which may be involved in energy
dissipation. Many studies have been performed on the
metabolic regulation of UCP3 mRNA level, but little is
known about UCP3 expression at the protein level. Two
populations of mitochondria have been described in skeletal
muscle, subsarcolemmal (SS) and intermyofibrillar (IMF),
which differ in their intracellular localization and possibly
also their metabolic role. To examine if UCP3 is differen-
tially expressed in these two populations and in different
mouse muscle types, we developed a new protocol for
isolation of SS and IMF mitochondria and carefully valid-
ated a new UCP3 antibody. The data show that the density
of UCP3 is higher in the mitochondria of glycolytic muscles
(tibialis anterior and gastrocnemius) than in those of oxi-
dative muscle (soleus). They also show that SS mitochondria
contain more UCP3 per mg of protein than IMF mito-
chondria. Taken together, these results suggest that oxida-
tive muscle and the mitochondria most closely associated
with myofibrils are most efficient at producing ATP. We
then determined the effect of a 24-h fast, which greatly
increases UCP3 mRNA (16.4-fold) in muscle, on UCP3
protein expression in gastrocnemius mitochondria. We
found that fasting moderately increases (1.5-fold) or does
not change UCP3 protein in gastrocnemius SS or IMF
mitochondria, respectively. These results show that modu-
lation of UCP3 expression at the mRNA level does not
necessarily result in similar changes at the protein level and
indicate that UCP3 density in SS and IMF mitochondria can
be differently affected by metabolic changes.
Keywords: fasting; intermyofibrillar mitochondria; muscle
type; subsacorlemmal; uncoupling protein-3 (UCP3).
The first uncoupling protein described, uncoupling protein-1
(UCP1), is an inner-mitochondrial membrane protein,
which, by dissipating the mitochondrial proton gradient
driven by the respiratory chain, uncouples oxidation from
phosphorylation and therefore produces heat instead of
ATP. UCP1 was found to be exclusively expressed in brown
adipose tissue (for review see [1]).
The novel UCP3, discovered in 1997, is abundantly
expressed in rodent and human skeletal muscle. Its high
sequence homology with UCP1 suggested that it had similar
uncoupling activities [2]. In fact, using heterologous yeast
and mammalian cell expression systems, UCP3 was shown
to decrease the mitochondrial membrane potential, as
measured by uptake of potential sensitive fluorescent dyes
(reviewed in [3–5]). Also recent data obtained using muscle
mitochondria of UCP3 knockout (UCP3KO) mice [6,7] and
of transgenic mice overexpressing UCP3 in their skeletal
muscle [8] confirmed the uncoupling activity of UCP3. A
more recent study clearly established that UCP3 is, like
UCP1, a H
+
transporter sensitive to nucleotides and fatty
acids [9].
Many studies have been performed on the metabolic
regulation of brown adipose tissue and muscle UCP3
mRNA expression in both rodents and humans (for review
see [3–5]). Very few of the control mechanisms of UCP3
observed in muscle at the mRNA level have so far been
studied at the protein level. The reasons for this are the
difficulty in obtaining specific antibodies and validation
tests and also good Western blot conditions.
Skeletal muscle mitochondria consist of two distinct
subfractions, the subsarcolemmal (SS) and intermyofibrillar
(IMF) mitochondria, located beneath the sarcolemma and
between the myofibrils, respectively. These two mitochond-
rial populations possess different characteristics, such as
higher cardiolipin content and more elevated state-3 respir-
ation rate in IMF mitochondria [10].
In this study, we validated an antibody to UCP3 using a
fully controlled Western blot technique and present a
comparative study in mice of UCP3 protein expression in
SS and IMF mitochondria of various muscle types. We also
examined UCP3 protein expression in the two mitochon-
dria populations of fed and fasted mouse gastrocnemius
muscle.
Correspondence to P. Muzzin, De
´partement de Biochimie Me
´dicale,
Centre Me
´dical Universitaire, 1 rue Michel Servet,
CH-1211 Gene
`ve 4 Switzerland.
Fax: 41 22 702 5502, Tel.: 41 22 702 5492,
E-mail: Patrick.Muzzin@medecine.unige.ch.
Abbreviations: UCP, uncoupling protein; SS, subsarcolemmal;
IMF, intermyofibrillar; COX, cytochrome oxidase; UCP3KO,
UCP3 knockout.
(Received 17 January 2002, revised 12 April 2002,
accepted 23 April 2002)
Eur. J. Biochem. 269, 2878–2884 (2002) ÓFEBS 2002 doi:10.1046/j.1432-1033.2002.02953.x
MATERIALS AND METHODS
Bio-Rad Protein Assay and nonfat dry milk were purchased
from Bio-Rad Laboratories (Hercules, CA, USA). ECL kit
Hyperfilm ECL and Coomassie blue (PhastGelÒBlueR)
were obtained from Amersham International Biotech
(Amersham, Bucks, UK), the antibody to human UCP3
C-terminus (CabrX) from Research Diagnostics, Inc (San
Antonio, LA, USA) and the monoclonal antibody to the
cytochrome oxidase (COX) subunit IV were from Molecu-
lar Probes (Eugene, OR, USA). Goat anti-rabbit and anti-
mouse immunoglobulins were purchased from Santa Cruz
Biotechnology, Inc (Santa Cruz, CA, USA). Trizol reagent
was from Life Technologies (Basel, Switzerland). The
protease inhibitor cocktail was purchased from Sigma (St
Louis, MO, USA).
Animals
Three-month-old female C57BL/6J mice fed ad libitum a
standard laboratory chow and maintained under a 12-h
light/dark cycle at 23 °C were used. All animals were caged
individually during the experimental periods. Mice were
either fed ad libitum orfastedforaperiodof24hwithfree
access to water. The animals were killed by cervical
dislocation, and tibialis anterior, gastrocnemius and soleus
muscles were carefully dissected and kept on ice. In fasted
animals and the respective controls, one gastrocnemius
muscle was used for the mitochondria preparation and the
other for RNA isolation. All experiments were performed in
accordance with the Office Ve
´te
´rinaire de Gene
`ve author-
ization covering animal experiments.
Preparation of muscle mitochondria
SS and IMF mitochondria were prepared from skeletal
muscle by the following procedure. Muscle (50–250 mg)
was minced with scissors in 5 mL ice-cold homogenization
buffer containing 100 m
M
sucrose, 180 m
M
KCl, 10 m
M
EDTA, 5 m
M
MgCl
2
,1m
M
ATP, 50 m
M
Tris/HCl,
pH 7.4, and 0.06% protease inhibitor cocktail. They were
then homogenized using a Teflon pestle in an ice-cold glass
Potter–Elvehjem homogenizer (clearance 0.37 mm, 10 up
and down strokes, 1800 r.p.m.; clearance 0.12 mm, 2 up and
down strokes, 1800 r.p.m.). The homogenate was centri-
fuged at 1600 gfor 10 min at 4 °C. The pellet was kept at
4°C for the extraction of IMF mitochondria. The super-
natant was filtered through two layers of surgical gauze and
then centrifuged at 9200 gfor 10 min at 4 °C. The resulting
SS mitochondria pellet was suspended in the appropriate
volume of distilled water. Being located just beneath the
sarcolemmal membrane, the SS mitochondria are easier to
extract from the muscle by homogenization than IMF
mitochondria. In a first attempt to prepare IMF mitochon-
dria, we used the original technique of Krieger et al. [11],
which involves digestion by the Nagarse protease. The
latter, even when tightly controlled, was found by Western
blot analysis to degrade UCP3. Therefore we adopted
another technique in which we broke down myofibrils by
strong mechanical disruption with a tight-fitting homoge-
nizer. The 1600 gpellet was resuspended in 4 mL ice-cold
homogenization buffer containing 100 m
M
KCl, 1 m
M
EDTA, 5 m
M
MgSO
4
,1m
M
ATP, 50 m
M
Tris/HCl,
pH 7.4, and 0.06% protease inhibitor cocktail using a
Teflon pestle in an ice-cold glass Elvehjem homogenizer
(clearance 0.12 mm for 3 min, 1800 rpm). The resulting
homogenate was centrifuged at 1600 gfor 10 min at 4 °C.
After filtration through two layers of surgical gauze, the
supernatant was centrifuged at 15 000 gfor 45 min at 4 °C,
and the resulting IMF mitochondrial pellet was resuspended
in an appropriate volume of distilled water. Mitochondrial
protein concentrations were determined as described by
Bradford [12] using the Bio-Rad Protein Assay, with BSA as
a standard. Isolated mitochondria were stored at )20 °Cas
15-lg mitochondrial protein aliquots.
Western blotting
Purified muscle mitochondria (15 lg) were dried under
vacuum and resuspended in 10 lL loading buffer contain-
ing 50% glycerol, 5% SDS, 2.5% bromophenol blue and
0.5
M
Tris/HCl, pH 6.8. The samples were electrophoresed
on a 12% polyacrylamide/0.1% SDS gel, and transferred to
a poly(vinylidene difluoride) membrane by electroblotting
transfer with a buffer containing 10% methanol, 25 m
M
Tris/HCl, pH 6.8, and 190 m
M
glycine. The transfer was
performed for 15 h at 30 V, 70 mA and 4 °C. After blotting,
the gel was stained with 0.1% Coomassie blue to check
transfer efficiency. No band was visible below 50 kDa on
the gel. The membrane was blocked with a NaCl/P
i
buffer
containing 0.1% Tween and 2% nonfat dry milk. This same
buffer was used for all subsequent hybridizations. UCP3
protein was detected using CabrX at a concentration of
1lgÆmL
)1
. The membrane was washed twice in NaCl/P
i
containing 0.1% Tween and hybridized with a 1 : 1000
diluted goat anti-rabbit peroxidase-labeled secondary anti-
body. The signals were detected by chemiluminescence
using a standard ECL kit and developed Hyperfilm ECL
film. They were quantified by scanning photodensitometry
using ImageQuant Software 3.3 (Molecular Dynamics,
Sunnyvale, CA, USA). COX protein was detected as above
using a 1 : 1000 diluted monoclonal antibody specific for
COX subunit IV and a 1 : 1000 diluted goat anti-mouse
peroxidase-labeled secondary antibody. To compare the
UCP3 signals, linear standard curves were constructed using
increasing concentrations of the human and mouse UCP3
recombinant proteins provided by Dr Michele Chiesi at
Novartis (Basel, Switzerland) and Stratagene (La Jolla, CA,
USA), respectively. The specificity of the antibody to UCP3
was tested using UCP3KO muscle mitochondria, which
were described by Gong et al. [7] and generously provided
by Dr Mary Ellen Harper (University of Ottawa, Ottawa,
Ontario, Canada). The replication-defective recombinant
adenoviral vector that contains the human UCP3 cDNA
under the transcriptional control of the cytomegalovirus
promoter was constructed as previously described [13].
Real-time quantitative RT-PCR
Total muscle RNA was isolated using the Trizol reagent
technique according to the manufacturer’s instructions.
Oligo-dT first-strand cDNA was synthesized from 2 lg
total RNA using Superscript II reverse transcriptase.
Real-time PCR was performed using a Lightcycler rapid
thermal cycler system and designated software (Roche
Diagnostics Ltd, Rotkreuz, Switzerland) according to the
ÓFEBS 2002 UCP3 protein quantitation (Eur. J. Biochem. 269) 2879
manufacturer’s instructions. Reactions were performed in a
20-lL reaction mixture containing 50 ngÆlL
)1
of first-
strand cDNA, 0.5 l
M
primers and 2.4 m
M
MgCl
2
.Nucleo-
tides, Taq DNA polymerase, and buffer were included in the
Lightcycler-DNA Master SYB Green I mix (Roche Diag-
nostics). The PCR protocol consisted of 2 min of denatur-
ing at 95 °C, followed by 30 cycles with 95 °Cdenaturing
for 1 s, 56 °C annealing for 5 s and 72 °C extension for
16 s. The fluorescent product was detected at the end of the
72 °C extension period. To confirm the amplification
specificity, the PCR product was subjected to a melting
curve analysis and then agarose gel electrophoresis. A linear
standard curve was constructed using known concentra-
tions of a mouse UCP3 plasmid. The 10-fold serial dilutions
ranged between 3.0 ngÆlL
)1
and 3.0 pgÆlL
)1
. The concen-
trations of the experimental samples were calculated by
comparison with the standard curves. Background fluores-
cence was removed by setting a noise band. The number of
cycles at which the best-fit line through the log-linear
portion of each amplified curve intersected the noise band
was inversely proportional to the log copy number [14]. The
samples were also normalized against b-actin using the same
conditions as described above.
Northern blot analysis
Total RNA from gastrocnemius muscle was isolated using
the Trizol reagent technique. Total RNA (20 lg) was
separated on a 1.2% agarose/formaldehyde gel and trans-
ferred to nylon membrane as described by Boss et al.[16].
To detect UCP3 mRNA, we used a probe derived from a
full-length rat UCP3 cDNA [15]. The probe was labeled
by random priming with [a-
32
P]dCTP (Amersham).
Hybridization and washing were carried out as previously
reported [16]. Blots were exposed to Hyperfilm ECL films
(Amersham) at )80 °C with intensifying screens. The
signals on the autoradiograms were quantified by scanning
photodensitometry using ImageQuant Software version
3.3. Hybridization of the blots with a [c-
32
P]ATP-labeled
synthetic oligonucleotide specific for the 18S rRNA
subunit was used to correct for differences in the amounts
of RNA loaded on to the gel. Student’s unpaired ttest
was used to determine statistical significance.
RESULTS
Validation of antibodies to UCP3
Table 1 shows a list of antibodies that have been used for
the Western blot analysis of UCP3 protein expression in
rodents. The studies performed on UCP3KO or transgenic
mice overexpressing UCP3 in their skeletal muscle provide
convincing validation of the antibodies used. The Lilly
antibody to mouse and rat UCP3 [6] and the Chemicon
antibody to human UCP3 (AB3046) [7] were found to react
specifically with mouse UCP3, as the signal observed in the
wild-type animal was found to be abolished in UCP3KO
mouse muscle. The a-Diagnostic antibody to human UCP3
(UCP32-A) was found to cross-react specifically with
human UCP3 as validated in a UCP3 transgenic mouse
model [8]. In the other studies in Table 1, in which the
possible modulations of UCP3 at the protein level were
analysed, validated Lilly, Chemicon and a-Diagnostic
antibodies were used [17–21]. Pedraza et al.[22]usedan
antibody to human UCP3 from a-Diagnostic (UCP31-A)
which was not validated in UCP3 transgenic mice but using
human UCP3 transfected cells.
In this study, we used a new antibody to human UCP3
C-terminus from Research Diagnostics (CabrX) and devel-
oped a Western-blot technique that optimizes protein
transfer. We obtained a 34-kDa UCP3 signal that was
validated using a UCP3KO mouse model, adenovirus
human UCP3-transfected cells and recombinant UCP3.
In our hands, the CabrX antibody showed higher
sensitivity than the other commercial antibodies listed in
Table 1.
Table 1. Western blot analysis of rodent muscle mitochondria with UCP3 antibodies. TM3, 3rd transmembrane domain; TM4, 4th transmembrane
domain; h, human.
Reference Antibody name (supplier) Transgenic animals Transfected cells
Species
(muscle mitochondria)
Vidal-Puig et al. [6] Peptide sequence between
TM3 and TM4 of mouse
and rat UCP3 (Lilly)
UCP3KO – Mouse muscle
Gong et al. [7] C-Terminus of human UCP3,
AB3046 (Chemicon)
UCP3KO – Mouse muscle
Cadenas et al. [17] C-Terminus of human UCP3,
AB3046 (Chemicon)
– hUCP3/HEK293 Rat muscle (starvation)
Zhou et al. [19] C-Terminus of human UCP3,
AB3046 (Chemicon)
– – Rat muscle (exercise, hypoxia,
AMPkinase activation)
Clapham et al. [8] C-Terminus of human UCP3,
UCP32-A (a-Diagnostic)
hUCP3Tg – Mouse muscle
Sivitz et al. [18] C-Terminus of human UCP3,
UCP32-A (a-Diagnostic)
– – Rat muscle (fasting, leptin)
Jucker et al. [20,21] C-Terminus of human UCP3,
UCP32-A (a-Diagnostic)
– – Rat muscle (fasting, T3)
Pedraza et al. [22] Peptide sequence between
TM2 and TM3 of human
UCP3, UCP31-A (a-Diagnostic)
– hUCP3/HEK293 Mouse muscle (lactation)
2880 M. Jimenez et al.(Eur. J. Biochem. 269)ÓFEBS 2002
Muscle mitochondria prepared from UCP3KO mice [7]
were compared with wild-type mitochondria. As shown in
Fig. 1A lanes 1 and 2, the strong signal observed in wild-
type mouse mitochondria was absent from those of
UCP3KO mice. Figure 1A (lane 3) shows that the CabrX
antibody reacts with the mouse recombinant protein. The
size of the signal is higher than 34 kDa because of the
presence of a His
6
tag in the mouse recombinant protein.
C
2
C
12
cells, which do not express UCP3, were infected
with an adenovirus containing the human UCP3 gene. As
shown in Fig. 1B, no signal was observed in the wild-type
C
2
C
12
cells whereas the human UCP3 was detected, at the
expected size of 34 kDa, in the infected cells and in a sample
of the human UCP3 recombinant protein.
Taken together these results demonstrate that the 34-kDa
signal observed in our Western blots is due to a specific
interaction between the CabrX antibody and mouse or
human UCP3.
Figure 2A shows that the UCP3 signal of human
recombinant protein interacting with the antibody to
human UCP3 increases linearly as a function of increasing
amounts of the protein over the relatively large range
5–30 ng. Figure 2B shows data from a similar experiment
performed with mouse recombinant protein. Representative
signals obtained at different concentrations of recombinant
protein are shown under the figures. The times of exposure
werethesameforFig2AandB.
The reproducibility of the Western blot quantification
was analyzed using mouse gastrocnemius and tibialis muscle
mitochondria. The mean variation between quadruplicates
for four different samples was 27 ± 7% and 20 ± 6% for
UCP3 and COX, respectively. It should be stressed that
larger and unpredictable variations were observed when
values obtained with a given sample on two different gels
were compared. Therefore we only compared values
obtained on the same gel for all our subsequent quantitative
studies.
Preparation of SS and IMF mitochondria
We developed a technique using selective conditions of
mechanical disruption to prepare SS and IMF mitochon-
dria. As shown in Table 2, the quantity of IMF mitochon-
dria recovered from 1 g gastrocnemius muscle was 1.7-fold
higher than SS mitochondria. The specific and total levels of
COX protein were not significantly different in IMF and SS
mitochondria. The yield in mitochondria, which was
determined by comparing the level of COX protein in the
sum of the two mitochondria populations with that in the
homogenate, was 88%.
Expression of UCP3 protein in SS and IMF mitochondria
of various muscles
Figure 3A illustrates the distribution of UCP3 in SS and
IMF mitochondria obtained from different types of mouse
muscle, i.e. tibialis anterior (two-thirds fast oxidative
glycolytic, one-third glycolytic), gastrocnemius (one-third
slow oxidative, one-third fast oxidative glycolytic, one-third
fast glycolytic) and soleus (90% slow oxidative). It can be
seen in Fig. 3A that the UCP3 protein levels in SS
mitochondria (expressed as arbitrary units per mg mitoch-
ondrial protein) are higher in the tibialis anterior and
gastrocnemius than in the soleus (1.4-fold and 1.7-fold,
respectively). The levels of UCP3 in IMF mitochondria are
also higher in the tibialis anterior and gastrocnemius
muscles than in the soleus muscle (2.2-fold and 1.8-fold,
respectively). UCP3 is expressed at a significantly lower level
in IMF than SS mitochondria in the three types of muscle
(by 37%, 58% and 46% in tibialis anterior, gastrocnemius
and soleus muscle, respectively). No difference was observed
in the level of COX per mg of mitochondrial protein in the
three muscle types and in IMF vs. SS mitochondria, except
Fig. 2. Increase in the UCP3 signal as a function of increasing amounts
of (A) human recombinant protein and (B) mouse recombinant protein.
Representative signals are shown under the figures.
Fig. 1. Western blot analysis. (A) Western-blot signals obtained with
20 lg mitochondria isolated from wild-type (lane 1) or UCP3KO (lane
2) mouse gastrocnemius. Lane 3, 20 ng mouse recombinant UCP3. (B)
20 lg homogenate from C
2
C
12
wild-type myoblasts (lane 1) and C
2
C
12
myoblasts infected with adenoviruses containing the human UCP3
gene (lane 2). Lane 3, 40 ng human recombinant UCP3. The immu-
noblots were hybridized with CabrX (Anti-hUCP3) antibody. They
were also hybridized with antibodies to COX (Anti-COX) and pro-
hibitin. Representative signals are shown under the figures.
Table 2. Recovery of SS and IMF mitochondria from gastrocnemius
muscle. The results are expressed as means ± SEM from the number
of experiments in parentheses.
SS IMF
Protein yield
(mg protein per g muscle)
1.9 ± 0.2 (4) 3.2 ± 0.2 (3)
a
COX protein specific level
(arbitrary units per mg protein)
131 ± 12 (4) 86 ± 26 (3)
COX protein total level
(arbitrary units per g muscle)
239 ± 14 (4) 265 ± 69 (3)
a
P< 0.01 in IMF vs. SS mitochondria.
ÓFEBS 2002 UCP3 protein quantitation (Eur. J. Biochem. 269) 2881
for the gastrocnemius, where the level of COX is lower in
IMF than SS mitochondria by 43% (Fig. 3B). As shown in
Fig. 3C, the UCP3/COX ratio in SS mitochondria is higher
in the gastrocnemius than in the soleus (1.5-fold) and in
IMF mitochondria in the tibialis anterior and in the
gastrocnemius than in the soleus (2.0-fold and 1.9-fold,
respectively). In the gastrocnemius and soleus muscles, the
UCP3/COX ratio is 37% and 41% lower, respectively, in
IMF than SS mitochondria. This indicates that the compo-
sitions of the two mitochondrial populations are different.
UCP3 mRNA was determined by quantitative RT-PCR
in the same muscles to allow a comparison between the
respective UCP3 mRNA and protein levels. As shown in
Fig. 4, UCP3 mRNA levels were higher in the tibialis
anterior and gastrocnemius muscles than in the soleus
muscle (1.7-fold and 2.1-fold, respectively). Therefore the
relative amounts of UCP3 protein and mRNA in the three
muscles are comparable.
Effect of fasting on UCP3 protein expression
We and others have shown that fasting induces upregula-
tion of UCP3 mRNA expression in skeletal muscle of mice
and rats (for review see [5]). To study further the regulation
of UCP3 in fasting, we measured the protein levels in SS and
IMF mitochondria of gastrocnemius muscle in 24 h-fasted
mice. Figure 5 illustrates the effects of 24-h fasting on the
expression of muscle UCP3 and COX per mg of protein in
both mitochondria populations. After a 24-h fast, the UCP3
protein level was increased 1.5-fold (P< 0.01) in SS
mitochondria, whereas it was unaffected in IMF mitochon-
dria. COX protein level was found to be unchanged by
fasting. In five animals from each group of mice, we also
Fig. 3. UCP3 protein levels (A) and COX protein levels (B) in mouse
tibialis anterior (TA), gastrocnemius (Gn) and soleus (So) muscle SS
(empty columns) and IMF (shaded columns) mitochondria (20 lg). (A)
The immunoblots were hybridized with CabrX antibody. The signals
were quantified by scanning photodensitometry and are presented as
means ± SEM of absolute values, n¼4–6. **P<0.02 and
***P< 0.001 vs. SS mitochondria; #P< 0.05 vs. tibialis anterior
values; °P<0.05 and °°°P< 0.005 vs. gastrocnemius values. (B)
Same as in (A) except that the immunoblots were hybridized with a
COX antibody. ***P< 0.005 vs. SS mitochondria. (C) UCP3 values
normalized using the corresponding COX values. *P<0.05 and
***P< 0.005 vs. SS mitochondria; #P< 0.05 vs. tibialis anterior
values; °°°P< 0.005 vs. gastrocnemius values.
Fig. 4. UCP3 mRNA levels in mouse tibialis anterior (TA), gastroc-
nemius (Gn) and soleus (So) muscle. The results, obtained by real-time
quantitative RT-PCR as described in Materials and Methods, are
presented as means ± SEM of values normalized using actin.
*P< 0.05 vs. gastrocnemius values.
2882 M. Jimenez et al.(Eur. J. Biochem. 269)ÓFEBS 2002